Drug: PLACEBO Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126180021 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 82.06 YR | M | 0 | 20160803 | GB |
126180091 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 76.67 YR | M | 0 | 20160803 | GB |
126180101 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 76.01 YR | M | 0 | 20160803 | GB |
126180121 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 82.19 YR | M | 0 | 20160803 | GB |
126263181 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 58.91 YR | F | 0 | 20160805 | GB |
126403741 | PLACEBO | Malignant neoplasm progression | ASTELLAS | 62.83 YR | M | 0 | 20160810 | GB |
Total Records: 6 Number of Pages: 1